The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction to Protein Structure
Branden, C. I., & Tooze, J. (2012) · Garland Science eBooks · doi:10.1201/9781136969898 · Cited by 2,382
Chi, E. Y., Krishnan, S., Randolph, T. W., & Carpenter, J. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1025771421906 · Cited by 1,379
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Self-citationConformation Changes of Proteins
Lumry, R., & Eyring, H. (1954) · The Journal of Physical Chemistry · doi:10.1021/j150512a005 · Cited by 864
Structural and functional changes in ultrasonicated bovine serum albumin solutions
Gülseren, İ., Güzey, D., Bruce, B. D., & Weiss, J. (2007) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2005.07.006 · Cited by 574
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Introduction to protein structure
Saffran, M. (1992) · Trends in Endocrinology & Metabolism · doi:10.1016/1043-2760(92)90006-m · Cited by 523
Cited by
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Self-citationImmunogenicity of therapeutic proteins: Influence of aggregation
Ratanji, K. D., Derrick, J. P., Dearman, R. J., & Kimber, I. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.821564 · Cited by 589
Kamerzell, T. J., Esfandiary, R., Joshi, S. B., Middaugh, C. R., & Volkin, D. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.006 · Cited by 510
Aggregates in monoclonal antibody manufacturing processes
Vázquez‐Rey, M., & Lang, D. A. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23155 · Cited by 479
Therapeutic protein aggregation: mechanisms, design, and control
Roberts, C. J. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.05.005 · Cited by 455
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22276 · Cited by 350
Singh, S. K., Afonina, N., Awwad, M., Bechtold-Peters, K., Blue, J. T., Chou, D., Cromwell, M., Krause, H.-J., Mahler, H.-C., Meyer, B. K., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22097 · Cited by 334
Self-citationClassification and Characterization of Therapeutic Antibody Aggregates
Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., & Narhi, L. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160457 · Cited by 316
Kishore, R. S. K., Kiese, S., Fischer, S., Pappenberger, A., Grauschopf, U., & Mahler, H.-C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0385-x · Cited by 299
Self-citationKey interactions of surfactants in therapeutic protein formulations: A review
Khan, T. A., Mahler, H.-C., & Kishore, R. S. K. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.016 · Cited by 287
Self-citationDegradation of Polysorbates 20 and 80: Studies on Thermal Autoxidation and Hydrolysis
Kishore, R. S. K., Pappenberger, A., Dauphin, I. B., Ross, A., Buergi, B., Staempfli, A., & Mahler, H.-C. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22290 · Cited by 285
Self-citationJoubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Forced degradation of recombinant monoclonal antibodies: A practical guide
Nowak, C., K. Cheung, J., M. Dellatore, S., Katiyar, A., Bhat, R., Sun, J., Ponniah, G., Neill, A., Mason, B., Beck, A., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1368602 · Cited by 260
Molecular origins of surfactant-mediated stabilization of protein drugs
Lee, H. J., McAuley, A., Schilke, K. F., & McGuire, J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.015 · Cited by 258
Impact of extractables/leachables from filters on stability of protein formulations
Huang, M., Horwitz, T. S., Zweiben, C., & Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22670 · Cited by 46
Friability Testing as a New Stress-Stability Assay for Biopharmaceuticals
Torisu, T., Maruno, T., Yoneda, S., Hamaji, Y., Honda, S., Ohkubo, T., & Uchiyama, S. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.035 · Cited by 35
Metadata
- Authors
- Kiese, S., Papppenberger, A., Friess, W., & Mahler, H.-C.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 97
- Issue
- 10
- Pages
- 4347-4366
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1988834123
- Cited by
- 397
- References
- 36
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.